The new CEO of spray-on skin company Avita Medical says there is a “pot of gold” on the horizon for the biotech company, but admits the business has a lot of work to do to prove itself to investors.
The ASX and NASDAQ dual-listed company, once called Clinical Cell Culture was, made famous as the developer of former Australian of the Year Fiona Wood’s skin repair technology used to treat victims of the Bali bombings.
Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
